The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Wysenski Nancy since year 2005.
The trader's CIK number is 1294596.
At the time of the last reporting, Wysenski Nancy was the EVP, Chief Commercial Officer of Alkermes Plc. .
(stock ticker symbol ALKS).
See this page for all insider trading activities at Alkermes Plc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2012-05-14||VRTX||Vertex Pharmaceuticals Inc / Ma||Option Ex||180,000||39.02||7,022,700|
|2012-05-14||VRTX||Vertex Pharmaceuticals Inc / Ma||Sale||180,000||64.64||11,634,300|
|2012-05-07||VRTX||Vertex Pharmaceuticals Inc / Ma||Sale||147,695||54.50||8,049,377|
|2012-05-08||VRTX||Vertex Pharmaceuticals Inc / Ma||Sale||38,009||61.60||2,341,240|
|2012-05-07||VRTX||Vertex Pharmaceuticals Inc / Ma||Option Ex||142,695||38.01||5,423,123|
|2012-05-08||VRTX||Vertex Pharmaceuticals Inc / Ma||Option Ex||38,009||37.44||1,423,056|
|2012-01-19||VRTX||Vertex Pharmaceuticals Inc / Ma||Sale||6,042||37.00||223,554|
|2011-12-12||VRTX||Vertex Pharmaceuticals Inc / Ma||Sale||5,000||28.90||144,500|
|2011-11-15||VRTX||Vertex Pharmaceuticals Inc / Ma||Sale||606||29.77||18,040|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wysenski Nancy (EVP, Chief Commercial Officer of Alkermes Plc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.